 "Shivinder Singh and Malvinder Singh")
Japanese pharma firm Daiichi Sankyo approached Delhi high court once again on Tuesday, to block former Ranbaxy promoters Malvinder Singh and Shivinder Singh from selling their stake in Fortis Healthcare.
The court asked the Singh brothers to file a reply before Monday, when next hearing will take place. In its application, Daiichi claimed that the Singh brothers have failed to file details of their debt-free assets in the correct format, as directed by the court on January 23.
Daiichi had approached the Delhi high court last year, seeking enforcement of a Rs 2,562-crore Singapore arbitration award against the
The court asked the Singh brothers to file a reply before Monday, when next hearing will take place. In its application, Daiichi claimed that the Singh brothers have failed to file details of their debt-free assets in the correct format, as directed by the court on January 23.
Daiichi had approached the Delhi high court last year, seeking enforcement of a Rs 2,562-crore Singapore arbitration award against the
